Hound Partners LLC Sells 3,535 Shares of HCA Healthcare, Inc. $HCA

Hound Partners LLC reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,832 shares of the company’s stock after selling 3,535 shares during the quarter. HCA Healthcare makes up about 1.6% of Hound Partners LLC’s investment portfolio, making the stock its 17th largest holding. Hound Partners LLC’s holdings in HCA Healthcare were worth $12,195,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $1,152,408,000. Price T Rowe Associates Inc. MD increased its holdings in HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after acquiring an additional 1,091,416 shares during the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares in the last quarter. Abdiel Capital Advisors LP bought a new position in HCA Healthcare during the first quarter valued at approximately $164,835,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $109,337,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HCA shares. UBS Group increased their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Oppenheimer boosted their price objective on shares of HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Finally, The Goldman Sachs Group upped their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $475.95.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $484.67 on Friday. The stock has a market cap of $110.60 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.42 and a beta of 1.36. The stock has a 50-day moving average of $465.59 and a two-hundred day moving average of $413.62. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 EPS. HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.